Delivra Health Brands Stock Net Income
| DHB Stock | 0.19 0.01 5.56% |
As of the 13th of February 2026, Delivra Health shows the Variance of 33.11, standard deviation of 5.75, and Mean Deviation of 3.86. Delivra Health Brands technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Delivra Health Brands standard deviation, treynor ratio, as well as the relationship between the Treynor Ratio and potential upside to decide if Delivra Health Brands is priced favorably, providing market reflects its regular price of 0.19 per share.
Delivra Health Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.3516 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 1 M | 1.1 M | |
| Net Income | 1 M | 1.1 M | |
| Net Loss | (0.04) | (0.04) | |
| Net Income Per E B T | 1.13 | 0.98 |
Delivra | Net Income |
The evolution of Net Income for Delivra Health Brands provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Delivra Health compares to historical norms and industry peers.
Latest Delivra Health's Net Income Growth Pattern
Below is the plot of the Net Income of Delivra Health Brands over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Delivra Health Brands financial statement analysis. It represents the amount of money remaining after all of Delivra Health Brands operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Delivra Health's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Delivra Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 876 K | 10 Years Trend |
|
Net Income |
| Timeline |
Delivra Net Income Regression Statistics
| Arithmetic Mean | (48,851,990) | |
| Coefficient Of Variation | (79.39) | |
| Mean Deviation | 36,476,482 | |
| Median | (79,857,000) | |
| Standard Deviation | 38,784,551 | |
| Sample Variance | 1504.2T | |
| Range | 80.9M | |
| R-Value | 0.87 | |
| Mean Square Error | 376.6T | |
| R-Squared | 0.77 | |
| Slope | 6,718,887 | |
| Total Sum of Squares | 24067.9T |
Delivra Net Income History
Delivra Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Delivra Health is extremely important. It helps to project a fair market value of Delivra Stock properly, considering its historical fundamentals such as Net Income. Since Delivra Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Delivra Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Delivra Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Delivra Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Delivra Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Delivra Health.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Delivra Health on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Delivra Health Brands or generate 0.0% return on investment in Delivra Health over 90 days. Delivra Health is related to or competes with Crescita Therapeutics, and Avant Brands. Delivra Health is entity of Canada. It is traded as Stock on V exchange. More
Delivra Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Delivra Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Delivra Health Brands upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 29.02 | |||
| Value At Risk | (8.82) | |||
| Potential Upside | 9.09 |
Delivra Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Delivra Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Delivra Health's standard deviation. In reality, there are many statistical measures that can use Delivra Health historical prices to predict the future Delivra Health's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.68) | |||
| Total Risk Alpha | (1.10) | |||
| Treynor Ratio | (5.86) |
Delivra Health February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (5.85) | |||
| Mean Deviation | 3.86 | |||
| Coefficient Of Variation | (872.82) | |||
| Standard Deviation | 5.75 | |||
| Variance | 33.11 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.68) | |||
| Total Risk Alpha | (1.10) | |||
| Treynor Ratio | (5.86) | |||
| Maximum Drawdown | 29.02 | |||
| Value At Risk | (8.82) | |||
| Potential Upside | 9.09 | |||
| Skewness | 0.6891 | |||
| Kurtosis | 2.42 |
Delivra Health Brands Backtested Returns
Delivra Health Brands secures Sharpe Ratio (or Efficiency) of -0.11, which denotes the company had a -0.11 % return per unit of risk over the last 3 months. Delivra Health Brands exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Delivra Health's Mean Deviation of 3.86, standard deviation of 5.75, and Variance of 33.11 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.11, which means not very significant fluctuations relative to the market. As returns on the market increase, Delivra Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Delivra Health is expected to be smaller as well. At this point, Delivra Health Brands has a negative expected return of -0.62%. Please make sure to confirm Delivra Health's total risk alpha, accumulation distribution, period momentum indicator, as well as the relationship between the potential upside and day median price , to decide if Delivra Health Brands performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.44 |
Average predictability
Delivra Health Brands has average predictability. Overlapping area represents the amount of predictability between Delivra Health time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Delivra Health Brands price movement. The serial correlation of 0.44 indicates that just about 44.0% of current Delivra Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.44 | |
| Spearman Rank Test | 0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Delivra Net Interest Income
Net Interest Income |
|
Based on the recorded statements, Delivra Health Brands reported net income of 876 K. This is 99.74% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The net income for all Canada stocks is 99.85% higher than that of the company.
Delivra Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Delivra Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Delivra Health could also be used in its relative valuation, which is a method of valuing Delivra Health by comparing valuation metrics of similar companies.Delivra Health is currently under evaluation in net income category among its peers.
Delivra Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Delivra Health from analyzing Delivra Health's financial statements. These drivers represent accounts that assess Delivra Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Delivra Health's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 7.6M | 2.5M | 8.6M | 5.5M | 6.3M | 6.0M | |
| Enterprise Value | 8.6M | 1.8M | 6.4M | 4.3M | 5.0M | 4.7M |
Delivra Fundamentals
| Return On Equity | -0.18 | ||||
| Return On Asset | -0.0302 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | (0.01) % | ||||
| Current Valuation | 4.56 M | ||||
| Shares Outstanding | 31.26 M | ||||
| Shares Owned By Insiders | 11.60 % | ||||
| Shares Owned By Institutions | 1.86 % | ||||
| Number Of Shares Shorted | 1.21 K | ||||
| Price To Book | 1.34 X | ||||
| Price To Sales | 0.42 X | ||||
| Revenue | 12.38 M | ||||
| Gross Profit | 6.68 M | ||||
| EBITDA | 512 K | ||||
| Net Income | 876 K | ||||
| Total Debt | 242 K | ||||
| Book Value Per Share | 0.14 X | ||||
| Cash Flow From Operations | 756 K | ||||
| Short Ratio | 0.05 X | ||||
| Earnings Per Share | (0.02) X | ||||
| Target Price | 0.73 | ||||
| Beta | 0.65 | ||||
| Market Capitalization | 5.63 M | ||||
| Total Asset | 10.05 M | ||||
| Retained Earnings | (169.16 M) | ||||
| Working Capital | 5.68 M | ||||
| Net Asset | 10.05 M |
About Delivra Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Delivra Health Brands's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Delivra Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Delivra Health Brands based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Delivra Stock Analysis
When running Delivra Health's price analysis, check to measure Delivra Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Delivra Health is operating at the current time. Most of Delivra Health's value examination focuses on studying past and present price action to predict the probability of Delivra Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Delivra Health's price. Additionally, you may evaluate how the addition of Delivra Health to your portfolios can decrease your overall portfolio volatility.